|
2024
|
Invention
|
Compositions of conjugated and unconjugated proteins. Provided herein are pharmaceutical composit... |
|
|
Invention
|
Methods for analyzing mixed compositions of protein and protein conjugates. Provided herein are m... |
|
|
Invention
|
Il-6 antibodies and fusion constructs and conjugates thereof.
The present invention provides ant... |
|
|
Invention
|
High molecular weight zwitterion-containing polymers.
The present invention provides multi-armed... |
|
|
Invention
|
Multivalent trap-antibody fusions. The present disclosure relates to multivalent antibody fusions... |
|
|
Invention
|
Antibodies to htra1 and conjugates thereof. Antibodies that bind to HTRA1 and conjugates thereof ... |
|
|
Invention
|
Organic compounds as nlrp3 inhibitors. Disclosed herein are small molecule compounds that are cap... |
|
2023
|
Invention
|
Formulations for dual vegf/il-6 inhibitors. The present disclosure provides formulations comprisi... |
|
|
P/S
|
Scientific research and design and consultation in the
fields of biochemical, biological, biotec... |
|
|
P/S
|
Scientific research and design and consultation in the fields of biochemical, biological, biotech... |
|
|
Invention
|
Methods of treating an eye disorder.
Provided herein are methods of treating eye disorders by ad... |
|
|
Invention
|
Multifunctional zwitterionic polymer conjugates.
The present invention provides random copolymer... |
|
|
Invention
|
Method of concentrating a solution or formulation. Some aspects of the present disclosure are dir... |
|
|
Invention
|
Nlrp3 inhibitors. Disclosed herein are small molecule compounds that are capable of inhibiting NL... |
|
|
P/S
|
Chemical, biochemical, biological and biotechnological preparations for use in the pharmaceutical... |
|
|
Invention
|
Methods of purifying a product. Provided herein are embodiments relating to affinity chromatograp... |
|
|
Invention
|
Methods of purifying a product.
Provided herein are embodiments relating to affinity chromatogra... |
|
|
Invention
|
Factor viii zwitterionic polymer conjugates.
The present invention provides multi-armed high MW ... |
|
|
Invention
|
Complement factor d antagonist antibodies and conjugates thereof.
The present invention provides... |
|
2022
|
Invention
|
Methods of treating an eye disorder.
Provided herein are embodiments relating to treating variou... |
|
|
Invention
|
Methods of treating an eye disorder. Provided herein are embodiments relating to treating various... |
|
2021
|
Invention
|
Acryloyloxyethylphosphorylcholine containing polymer conjugates and their preparation.
The prese... |
|
|
Invention
|
Use of il-6 antibodies and vegf traps, and fusion constructs and conjugates thereof.
The present... |
|
|
Invention
|
Use of il-6 antibodies and vegf traps, and fusion constructs and conjugates thereof. The present ... |
|
|
Invention
|
Antibodies and conjugates thereof.
Provided herein are anti-VEGF-A antibodies and antibody conju... |
|
2020
|
Invention
|
Methods of treating an eye disorder. Provided herein are methods of treating eye disorders by adm... |
|
|
Invention
|
Methods of treating an eye disorder. e.ge.g., human or other mammalian patient) in need of treati... |
|
|
Invention
|
Dual pdgf/vegf antagonists.
The invention provides a dual VEGF/PDGF antagonist comprising a VEGF... |
|
|
Invention
|
Factor viii zwitterionic polymer conjugates. The present invention provides multi-armed high MW p... |
|
2019
|
Invention
|
Butyrylcholinesterase zwitterionic polymer conjugates. The present invention provides recombinant... |
|
|
Invention
|
Il-6 antibodies and fusion constructs and conjugates thereof. The present invention provides anta... |
|
2018
|
Invention
|
Complement factor d antagonist antibodies and conjugates thereof. The present invention provides ... |
|
|
P/S
|
Chemical, biochemical, biological and biotechnological proprietary preparations for use in the ma... |
|
2017
|
Invention
|
Dual pdgf/vegf antagonists. The invention provides a dual VEGF/PDGF antagonist comprising a VEGF ... |
|
2016
|
Invention
|
Antibodies and conjugates thereof. Provided herein are anti-VEGF-A antibodies and antibody conjug... |
|
|
Invention
|
Targeted drug phosphorylcholine polymer conjugates.
The present invention provides random copoly... |
|
|
Invention
|
Multifunctional zwitterionic polymer conjugates. The present invention provides random copolymers... |
|
2015
|
P/S
|
Chemical preparations for use in the pharmaceutical industry, namely, chemical additives for use ... |
|
|
P/S
|
Chemical preparations for use in the pharmaceutical industry, namely, chemical additives for use ... |
|
|
P/S
|
Pharmaceutical drugs and medicines to treat ophthalmic diseases, and diagnostic reagents for medi... |
|
|
P/S
|
pharmaceutical drugs and medicines to treat ophthalmic diseases and diagnostic reagents for medic... |
